The Pierre Fabre Group has long been a dominant force in therapeutic skincare as the second largest dermocosmetic company in the world and the second largest private French pharmaceutical group. Power brands in the company’s stable include Eau Thermale Avène, Klorane, A-Derma and Rene Furterer.
Last year, Pierre Fabre reported a global turnover of 2.7 billion euros (AUD$4.42 billion), 69 per cent of which was generated in international markets including Australia.
Five years ago, Pierre Fabre bought a 5 per cent stake in Même, the first dermocosmetic developed for people experiencing the side effects of cancer treatments. The multinational has now acquired the brand from its co-founders and investors.
The distribution network of Eau Thermale Avène has been instrumental in creating a strong presence for Même in France and 10 other countries, including Germany, Spain, Italy and China. Currently sold in 4800 drugstores and pharmacies, the brand has enormous growth potential as cancer rates increase worldwide.
Même was launched in 2017 by co-founders Judith Levy and Juliette Couturier, who both suffered from the effects of cancer treatment on their skin, hair and mucous membranes. Levy and Couturier will continue to helm the brand following the acquisition. The naturally-based brand was developed in collaboration with leading oncologists and dermatologists and donates 1 per cent of its sales to cancer research.
In addition to skincare, Même’s 46 SKU range also includes makeup and nail products
Through this acquisition, we confirm our strategy of investing in innovative brands and products in our priority areas of oncology, dermatology and dermocosmetics, added Eric Ducournau, CEO of the Pierre Fabre Group.
“Through its positioning, Même is at the very crossroads of these three strategic priorities. When I first met Judith and Juliette five years ago, I realised very quickly that we shared common values and that their project had strong development potential. We will now continue to write this meaningful story together in service to those affected by cancer”.
For further information in English, go to www.memecosmetics.fr.
Read the current issue of our digital magazine below:
- For more news and updates, subscribe to our weekly newsletter
- Follow us on Instagram
- Like us on Facebook
- Connect with us on LinkedIn